UltraSight™ Selected for MedTech Innovator’s 2026 Accelerator Cohort and Inaugural MTI Index
Summary
UltraSight has been selected for MedTech Innovator’s 2026 Accelerator Cohort and the inaugural MTI Index. The company builds AI-guided cardiac imaging software that helps clinicians capture diagnostic-quality ultrasound images with real-time guidance and quality assessment. The accelerator gives UltraSight access to mentorship, commercialization support, investor engagement, and strategic introductions. The announcement also highlights UltraSight’s FDA 510(k)-cleared software and its focus on expanding access to echocardiography across multiple care settings.
Classifications
industries
HealthTech
applications
AI & Machine learning
AskAI Classifications
Labels
Healthcare Software
AI/ML Software
Clinical Decision Support
Linked Companies
UltraSight
$1M to $5M